SQ109 CAS:502487-67-4


Catalog # Pkg Size Price(USD) Quantity Buy this product
R-C-1312 10mg 280.00
- +
+ Add to cart
R-C-1312 50mg 790.00
- +
+ Add to cart
R-C-1312 100mg 920.00
- +
+ Add to cart

Product description

SQ109 is a drug undergoing development for treatment of tuberculosis.SQ109 showed activity against both drug susceptible and Multi-drug-resistant tuberculosis bacteria,including Extensively drug-resistant tuberculosis strains. In preclinical studies SQ109 enhanced the activity of anti-tubercular drugs isoniazid and rifampin and reduced by >30% the time required to cure mice of experimental TB.SQ109 is being developed by OOO Infectex in Russia and by Sequella Inc internationally.I

SQ109      CAS:502487-67-4

Appearance N/A
Molecular Weight N/A
purity >95%
PDI by GPC <1.5
Solubility N/A
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 2 weeks
Stability 1 year

Related Product